← All Virginia bills

HB1025Introduced in the House of Delegates

Access to investigational drugs, etc.; patient with severely debilitating condition.

IntroducedHouse Health and Human Services

Introduced by Wendell Walker, District 52

What does this bill do?

Plain-English breakdown

Writing a plain-English summary of this bill… this can take a few seconds the first time.

Official description

Access to investigational drugs, biological products, and devices; patient with severely debilitating condition. Allows a patient who has a severely debilitating condition, defined in the bill as a disease or condition that causes major irreversible morbidity, to access investigational drugs, biological products, and devices when certain criteria are met. Under current law, only a patient who has a terminal condition may access such drugs, products, and devices.

Where it stands

Left in Committee Health and Human Services

February 18, 2026

How did lawmakers vote?

House of DelegatesStage: Subcommittee recommends laying on the table (7-Y 1-N) · February 10, 2026

7

Yes

1

No

2

Absent or Not Voting

10 delegates recorded in this House of Delegates vote. Colors show vote categories only, not whether a vote was good or bad.

What do people think?

Citizen Voice

How would you vote on this bill?

An unofficial public opinion poll. It does not affect the bill or the official vote.

One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.

See how each delegate voted

Bill history

  1. Prefiled and ordered printed; Offered 01-14-2026 26102452D

  2. Referred to Committee on Health and Human Services

  3. Assigned sub: Health

  4. Fiscal Impact Statement from Department of Planning and Budget (HB1025)

  5. Subcommittee recommends laying on the table (7-Y 1-N)

  6. Left in Committee Health and Human Services

Verify the information

Our commitment to neutrality

We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.